Genetic diagnosis of prostate cancer

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) A61K 31/706 (2006.01) C12N 9/10 (2006.01)

Patent

CA 2195396

A method for detecting and a method for treating a cell proliferative disorder associated with glutathione-S-transferase (GSTP1) expression is provided. The method includes direct detection of a hypermethylated GSTP1 promoter, or indirect detection of decreased GSTP1 mRNA or GSTP1 protein in a suspect tissue sample.

L'invention concerne un procédé de détection et de traitement de troubles cellulaires prolifératifs associés à l'expression de la glutathione-S-transférase (GSTP1). Le procédé consiste à détecter directement un promoteur de la GSTP1 hyperméthylée, ou à détecter indirectement la déplétion de l'ARNm de GSTP1 ou de la protéine de GSTP1 dans un échantillon tissulaire suspect.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Genetic diagnosis of prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genetic diagnosis of prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic diagnosis of prostate cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1951705

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.